Download PDF
Facial Plast Surg 2020; 36(02): 180-185
DOI: 10.1055/s-0040-1709119
Original Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Radiotherapy in Cutaneous Squamous Cell and Basal Cell Carcinoma

Laila A. Gharzai 
1   Department of Radiation Oncology, University of Michigan, Ann Arbor, Michigan
,
Michelle L. Mierzwa
1   Department of Radiation Oncology, University of Michigan, Ann Arbor, Michigan
› Author Affiliations
Further Information

Publication History

Publication Date:
15 May 2020 (online)

    Permissions and Reprints

Abstract

Radiotherapy is a key component in the multidisciplinary treatment of skin cancers, used in definitive management of selected nonmelanomatous skin cancers and as an adjunct treatment in high-risk cases. Understanding the role of radiotherapy in nonmelanoma skin cancers is increasingly important as their incidence continues to rise. This article provides an overview of risk factors associated with nonmelanomatous skin cancers and the principles of both definitive and adjuvant radiotherapy.

Keywords

radiation - radiotherapy - skin cancer - basal cell carcinoma - squamous cell carcinoma
 

  • References

  • 1 World Health Organization. Skin cancers. Available at: https://www.who.int/uv/faq/skincancer/en/index1.html . Accessed January 10, 2020
    PubMed
  • 2 Karia PS, Han J, Schmults CD. Cutaneous squamous cell carcinoma: estimated incidence of disease, nodal metastasis, and deaths from disease in the United States, 2012. J Am Acad Dermatol 2013; 68 (06) 957-966
    CrossrefPubMedGoogle Scholar
  • 3 Rogers HW, Weinstock MA, Feldman SR, Coldiron BM. Incidence estimate of nonmelanoma skin cancer (keratinocyte carcinomas) in the U.S. Population, 2012. JAMA Dermatol 2015; 151 (10) 1081-1086
    CrossrefPubMedGoogle Scholar
  • 4 Rowe DE, Carroll RJ, Day Jr CL. Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip. Implications for treatment modality selection. J Am Acad Dermatol 1992; 26 (06) 976-990
    CrossrefPubMedGoogle Scholar
  • 5 Bøgelund FS, Philipsen PA, Gniadecki R. Factors affecting the recurrence rate of basal cell carcinoma. Acta Derm Venereol 2007; 87 (04) 330-334
    CrossrefPubMedGoogle Scholar
  • 6 Brougham ND, Dennett ER, Cameron R, Tan ST. The incidence of metastasis from cutaneous squamous cell carcinoma and the impact of its risk factors. J Surg Oncol 2012; 106 (07) 811-815
    CrossrefPubMedGoogle Scholar
  • 7 Silverman MK, Kopf AW, Grin CM, Bart RS, Levenstein MJ. Recurrence rates of treated basal cell carcinomas. Part 1: overview. J Dermatol Surg Oncol 1991; 17 (09) 713-718
    CrossrefPubMedGoogle Scholar
  • 8 Brantsch KD, Meisner C, Schönfisch B. , et al. Analysis of risk factors determining prognosis of cutaneous squamous-cell carcinoma: a prospective study. Lancet Oncol 2008; 09 (08) 713-720
    CrossrefPubMedGoogle Scholar
  • 9 Oddone N, Morgan GJ, Palme CE. , et al. Metastatic cutaneous squamous cell carcinoma of the head and neck: the immunosuppression, treatment, extranodal spread, and margin status (ITEM) prognostic score to predict outcome and the need to improve survival. Cancer 2009; 115 (09) 1883-1891
    CrossrefPubMedGoogle Scholar
  • 10 Thompson AK, Kelley BF, Prokop LJ, Murad MH, Baum CL. Risk factors for cutaneous squamous cell carcinoma recurrence, metastasis, and disease-specific death: a systematic review and meta-analysis. JAMA Dermatol 2016; 152 (04) 419-428
    CrossrefPubMedGoogle Scholar
  • 11 Karagas MR, McDonald JA, Greenberg ER. , et al; For The Skin Cancer Prevention Study Group. Risk of basal cell and squamous cell skin cancers after ionizing radiation therapy. J Natl Cancer Inst 1996; 88 (24) 1848-1853
    CrossrefPubMedGoogle Scholar
  • 12 Hinerman RW, Indelicato DJ, Amdur RJ. , et al. Cutaneous squamous cell carcinoma metastatic to parotid-area lymph nodes. Laryngoscope 2008; 118 (11) 1989-1996
    CrossrefPubMedGoogle Scholar
  • 13 Givi B, Andersen PE, Diggs BS, Wax MK, Gross ND. Outcome of patients treated surgically for lymph node metastases from cutaneous squamous cell carcinoma of the head and neck. Head Neck 2011; 33 (07) 999-1004
    CrossrefPubMedGoogle Scholar
  • 14 Wang JT, Palme CE, Morgan GJ, Gebski V, Wang AY, Veness MJ. Predictors of outcome in patients with metastatic cutaneous head and neck squamous cell carcinoma involving cervical lymph nodes: improved survival with the addition of adjuvant radiotherapy. Head Neck 2012; 34 (11) 1524-1528
    CrossrefPubMedGoogle Scholar
  • 15 Likhacheva A, Awan M, Barker CA. , et al. Definitive and postoperative radiation therapy for basal and squamous cell cancers of the skin: executive summary of an American Society for Radiation Oncology Clinical Practice Guideline. Pract Radiat Oncol 2020; 10 (01) 8-20
    CrossrefPubMedGoogle Scholar
  • 16 Zaorsky NG, Lee CT, Zhang E, Keith SW, Galloway TJ. Hypofractionated radiation therapy for basal and squamous cell skin cancer: a meta-analysis. Radiother Oncol 2017; 125 (01) 13-20
    CrossrefPubMedGoogle Scholar
  • 17 Drucker AM, Adam GP, Rofeberg V. , et al. Treatments of primary basal cell carcinoma of the skin: a systematic review and network meta-analysis. Ann Intern Med 2018; 169 (07) 456-466
    CrossrefPubMedGoogle Scholar
  • 18 Leibovitch I, Huilgol SC, Selva D, Hill D, Richards S, Paver R. Cutaneous squamous cell carcinoma treated with Mohs micrographic surgery in Australia I. Experience over 10 years. J Am Acad Dermatol 2005; 53 (02) 253-260
    CrossrefPubMedGoogle Scholar
  • 19 Petrovich Z, Kuisk H, Langholz B. , et al. Treatment results and patterns of failure in 646 patients with carcinoma of the eyelids, pinna, and nose. Am J Surg 1987; 154 (04) 447-450
    CrossrefPubMedGoogle Scholar
  • 20 Mazeron JJ, Chassagne D, Crook J. , et al. Radiation therapy of carcinomas of the skin of nose and nasal vestibule: a report of 1676 cases by the Groupe Europeen de Curiethérapie. Radiother Oncol 1988; 13 (03) 165-173
    CrossrefPubMedGoogle Scholar
  • 21 Lovett RD, Perez CA, Shapiro SJ, Garcia DM. External irradiation of epithelial skin cancer. Int J Radiat Oncol Biol Phys 1990; 19 (02) 235-242
    PubMedGoogle Scholar
  • 22 Babington S, Veness MJ, Cakir B, Gebski VJ, Morgan GJ. Squamous cell carcinoma of the lip: is there a role for adjuvant radiotherapy in improving local control following incomplete or inadequate excision?. ANZ J Surg 2003; 73 (08) 621-625
    CrossrefPubMedGoogle Scholar
  • 23 De Silva SP, Dellon AL. Recurrence rate of positive margin basal cell carcinoma: results of a five-year prospective study. J Surg Oncol 1985; 28 (01) 72-74
    CrossrefPubMedGoogle Scholar
  • 24 de Lima Vazquez V, Sachetto T, Perpetuo NM, Carvalho AL. Prognostic factors for lymph node metastasis from advanced squamous cell carcinoma of the skin of the trunk and extremities. World J Surg Oncol 2008; 06: 73
    CrossrefPubMedGoogle Scholar
  • 25 Porceddu SV. Prognostic factors and the role of adjuvant radiation therapy in non-melanoma skin cancer of the head and neck. Am Soc Clin Oncol Educ Book 2015; e513-e518
    PubMedGoogle Scholar
  • 26 Cherpelis BS, Marcusen C, Lang PG. Prognostic factors for metastasis in squamous cell carcinoma of the skin. Dermatol Surg 2002; 28 (03) 268-273
    PubMedGoogle Scholar
  • 27 Wermker K, Kluwig J, Schipmann S, Klein M, Schulze HJ, Hallermann C. Prediction score for lymph node metastasis from cutaneous squamous cell carcinoma of the external ear. Eur J Surg Oncol 2015; 41 (01) 128-135
    CrossrefPubMedGoogle Scholar
  • 28 Kyrgidis A, Tzellos TG, Kechagias N. , et al. Cutaneous squamous cell carcinoma (SCC) of the head and neck: risk factors of overall and recurrence-free survival. Eur J Cancer 2010; 46 (09) 1563-1572
    CrossrefPubMedGoogle Scholar
  • 29 Porceddu SV, Bressel M, Poulsen MG. , et al. postoperative concurrent chemoradiotherapy versus postoperative radiotherapy in high-risk cutaneous squamous cell carcinoma of the head and neck: the randomized phase III TROG 05.01 trial. J Clin Oncol 2018; 36 (13) 1275-1283
    CrossrefPubMedGoogle Scholar
  • 30 Sekulic A, Migden MR, Basset-Seguin N. , et al; ERIVANCE BCC Investigators. Long-term safety and efficacy of vismodegib in patients with advanced basal cell carcinoma: final update of the pivotal ERIVANCE BCC study. BMC Cancer 2017; 17 (01) 332
    CrossrefPubMedGoogle Scholar
  • 31 Migden MR, Rischin D, Schmults CD. , et al. PD-1 blockade with cemiplimab in advanced cutaneous squamous-cell carcinoma. N Engl J Med 2018; 379 (04) 341-351
    CrossrefPubMedGoogle Scholar
  • 32 Clayman GL, Lee JJ, Holsinger FC. , et al. Mortality risk from squamous cell skin cancer. J Clin Oncol 2005; 23 (04) 759-765
    CrossrefPubMedGoogle Scholar
  • 33 Ballantyne AJ. Perineural invasion by SCC. J Dermatol Surg Oncol 1984; 10 (07) 502-504
    CrossrefPubMedGoogle Scholar
  • 34 Leibovitch I, Huilgol SC, Selva D, Richards S, Paver R. Basal cell carcinoma treated with Mohs surgery in Australia III. Perineural invasion. J Am Acad Dermatol 2005; 53 (03) 458-463
    CrossrefPubMedGoogle Scholar
  • 35 Sapir E, Tolpadi A, McHugh J. , et al. Skin cancer of the head and neck with gross or microscopic perineural involvement: patterns of failure. Radiother Oncol 2016; 120 (01) 81-86
    CrossrefPubMedGoogle Scholar
  • 36 Han A, Ratner D. What is the role of adjuvant radiotherapy in the treatment of cutaneous squamous cell carcinoma with perineural invasion?. Cancer 2007; 109 (06) 1053-1059
    CrossrefPubMedGoogle Scholar
  • 37 Harris JP, Chen MM, Orosco RK, Sirjani D, Divi V, Hara W. Association of survival with shorter time to radiation therapy after surgery for US patients with head and neck cancer. JAMA Otolaryngol Head Neck Surg 2018; 144 (04) 349-359
    CrossrefPubMedGoogle Scholar
  • 38 Ko HC, Gupta V, Mourad WF. , et al. A contouring guide for head and neck cancers with perineural invasion. Pract Radiat Oncol 2014; 4 (06) e247-e258
    CrossrefPubMedGoogle Scholar
  • 39 Bakst RL, Glastonbury CM, Parvathaneni U, Katabi N, Hu KS, Yom SS. Perineural invasion and perineural tumor spread in head and neck cancer. Int J Radiat Oncol Biol Phys 2019; 103 (05) 1109-1124
    CrossrefPubMedGoogle Scholar
  • 40 Robinson JK, Dahiya M. Basal cell carcinoma with pulmonary and lymph node metastasis causing death. Arch Dermatol 2003; 139 (05) 643-648
    CrossrefPubMedGoogle Scholar
  • 41 Nehal KS, Bichakjian CK. Update on keratinocyte carcinomas. N Engl J Med 2018; 379 (04) 363-374
    CrossrefPubMedGoogle Scholar
  • 42 Ebrahimi A, Clark JR, Lorincz BB, Milross CG, Veness MJ. Metastatic head and neck cutaneous squamous cell carcinoma: defining a low-risk patient. Head Neck 2012; 34 (03) 365-370
    CrossrefPubMedGoogle Scholar
  • 43 Palme CE, O'Brien CJ, Veness MJ, McNeil EB, Bron LP, Morgan GJ. Extent of parotid disease influences outcome in patients with metastatic cutaneous squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 2003; 129 (07) 750-753
    CrossrefPubMedGoogle Scholar
  • 44 National Comprehensive Cancer Network. Basal cell skin cancer. Available at: https://www.nccn.org/professionals/physician_gls/pdf/nmsc.pdf . Published 2019. Accessed January 10, 2020
    PubMed
  • 45 National Comprehensive Cancer Network. Squamous cell skin cancer. Available at: https://www.nccn.org/professionals/physician_gls/pdf/squamous.pdf . Published 2019. Accessed January 10, 2020
    PubMed